These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26786213)

  • 21. Efficacy of Trabectedin in Patients with Advanced Translocation-Related Sarcomas: Pooled Analysis of Two Phase II Studies.
    Takahashi M; Takahashi S; Araki N; Sugiura H; Ueda T; Yonemoto T; Morioka H; Hiraga H; Hiruma T; Kunisada T; Matsumine A; Shimura M; Kawai A
    Oncologist; 2017 Aug; 22(8):979-988. PubMed ID: 28526720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What makes real world outcomes in soft tissue sarcomas? A mono-institutional trabectedin experience.
    Moriceau G; Vallard A; Méry B; Rivoirard R; Langrand-Escure J; Espenel S; Ben Mrad M; Wang G; Diao P; Fournel P; Collard O; Magné N
    Bull Cancer; 2015 Oct; 102(10):814-22. PubMed ID: 26384694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group.
    Khalifa J; Ouali M; Chaltiel L; Le Guellec S; Le Cesne A; Blay JY; Cousin P; Chaigneau L; Bompas E; Piperno-Neumann S; Bui-Nguyen B; Rios M; Delord JP; Penel N; Chevreau C
    BMC Cancer; 2015 Oct; 15():700. PubMed ID: 26472661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trabectedin in patients with metastatic soft tissue sarcoma: a retrospective single center analysis.
    Schur S; Lamm W; Köstler WJ; Hoetzenecker K; Nemecek E; Schwameis K; Klepetko W; Windhager R; Brodowicz T
    Anticancer Drugs; 2013 Aug; 24(7):725-30. PubMed ID: 23728219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial.
    Le Cesne A; Blay JY; Cupissol D; Italiano A; Delcambre C; Penel N; Isambert N; Chevreau C; Bompas E; Bertucci F; Chaigneau L; Piperno-Neumann S; Salas S; Rios M; Guillemet C; Bay JO; Ray-Coquard I; Haddag L; Bonastre J; Kapso R; Fraslin A; Bouvet N; Mir O; Foulon S
    Ann Oncol; 2021 Aug; 32(8):1034-1044. PubMed ID: 33932507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma.
    Schöffski P; Dumez H; Wolter P; Stefan C; Wozniak A; Jimeno J; Van Oosterom AT
    Expert Opin Pharmacother; 2008 Jun; 9(9):1609-18. PubMed ID: 18518789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy.
    Araki N; Takahashi S; Sugiura H; Ueda T; Yonemoto T; Takahashi M; Morioka H; Hiraga H; Hiruma T; Kunisada T; Matsumine A; Kawai A
    Eur J Cancer; 2016 Mar; 56():122-130. PubMed ID: 26845175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
    Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Thyss A; Bertucci F; Bompas E; Alexandre J; Collard O; Lavau-Denes S; Soulié P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
    Lancet Oncol; 2015 Apr; 16(4):457-64. PubMed ID: 25795402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Trabectedin registry].
    Kubácková K; Fínek J; Vyzula R; Zvaríková M; Vocka M; Batko S; Dreslerová J; Lazarov PP; Lysý M; Ptátková Z; Benesová V; Bortlícek Z; Kandrnal V
    Klin Onkol; 2011; 24(6):470-4. PubMed ID: 22257238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone.
    Paz-Ares L; López-Pousa A; Poveda A; Balañá C; Ciruelos E; Bellmunt J; del Muro JG; Provencio M; Casado A; Rivera-Herrero F; Izquierdo MA; Nieto A; Tanović A; Cortes-Funes H; Buesa JM
    Invest New Drugs; 2012 Apr; 30(2):729-40. PubMed ID: 20960029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin.
    Vincenzi B; Badalamenti G; Armento G; Silletta M; Spalato Ceruso M; Catania G; Napolitano A; Maltese G; Valeri S; Incorvaia L; Santini D; Tonini G
    Oncology; 2018; 95(1):1-7. PubMed ID: 29510410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trabectedin for sarcomas in daily clinical practice: analysis of 45 patients treated in a French institution.
    Daupin J; Paubel P; Fillon J; Debrix I; Soares DG; Lotz JP
    J Chemother; 2016 Dec; 28(6):494-499. PubMed ID: 27535294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution.
    Fayette J; Boyle H; Chabaud S; Favier B; Engel C; Cassier P; Thiesse P; Méeus P; Sunyach MP; Vaz G; Ray-Coquard I; Ranchère D; Decouvelaere AV; Alberti L; Pérol D; Blay JY
    Anticancer Drugs; 2010 Jan; 21(1):113-9. PubMed ID: 19887935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trabectedin for Advanced Soft Tissue Sarcoma: Ten Year Real-Life Perspective.
    Shamai S; Merimsky O
    Isr Med Assoc J; 2018 Oct; 20(10):599-603. PubMed ID: 30324774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of trabectedin and gemcitabine for advanced soft tissue sarcomas: results of a phase I dose escalating trial of the German Interdisciplinary Sarcoma Group (GISG).
    Kasper B; Reichardt P; Pink D; Sommer M; Mathew M; Rauch G; Hohenberger P
    Mar Drugs; 2015 Jan; 13(1):379-88. PubMed ID: 25591040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trabectedin for metastatic soft tissue sarcoma: a retrospective single center analysis.
    Schmitt T; Keller E; Dietrich S; Wuchter P; Ho AD; Egerer G
    Mar Drugs; 2010 Oct; 8(10):2647-58. PubMed ID: 21116412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.
    Martin-Broto J; Pousa AL; de Las Peñas R; García Del Muro X; Gutierrez A; Martinez-Trufero J; Cruz J; Alvarez R; Cubedo R; Redondo A; Maurel J; Carrasco JA; López-Martin JA; Sala Á; Meana JA; Ramos R; Martinez-Serra J; Lopez-Guerrero JA; Sevilla I; Balaña C; Vaz Á; De Juan A; Alemany R; Poveda A
    J Clin Oncol; 2016 Jul; 34(19):2294-302. PubMed ID: 27185843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?
    Ratan R; Patel SR
    Curr Treat Options Oncol; 2017 Jun; 18(6):34. PubMed ID: 28534249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.
    Demetri GD; von Mehren M; Jones RL; Hensley ML; Schuetze SM; Staddon A; Milhem M; Elias A; Ganjoo K; Tawbi H; Van Tine BA; Spira A; Dean A; Khokhar NZ; Park YC; Knoblauch RE; Parekh TV; Maki RG; Patel SR
    J Clin Oncol; 2016 Mar; 34(8):786-93. PubMed ID: 26371143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of 24-h intravenous infusions of trabectedin in ambulatory patients with mesenchymal tumors via disposable elastomeric pumps: an effective and patient-friendly palliative treatment option.
    Schöffski P; Cerbone L; Wolter P; De Wever I; Samson I; Dumez H; Clement P; Wildiers H; Stas M
    Onkologie; 2012; 35(1-2):14-7. PubMed ID: 22310339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.